These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33709107)

  • 21. Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine.
    Szot P; Franklin A; Miguelez C; Wang Y; Vidaurrazaga I; Ugedo L; Sikkema C; Wilkinson CW; Raskind MA
    Neuropharmacology; 2016 Feb; 101():76-86. PubMed ID: 26362360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia.
    Galgani A; Lombardo F; Martini N; Vergallo A; Bastiani L; Hampel H; Hlavata H; Baldacci F; Tognoni G; De Marchi D; Ghicopulos I; De Cori S; Biagioni F; Busceti CL; Ceravolo R; Bonuccelli U; Chiappino D; Siciliano G; Fornai F; Pavese N; Giorgi FS
    Eur J Neurol; 2023 Jan; 30(1):32-46. PubMed ID: 36086917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heightened Hippocampal β-Adrenergic Receptor Function Drives Synaptic Potentiation and Supports Learning and Memory in the TgF344-AD Rat Model during Prodromal Alzheimer's Disease.
    Goodman AM; Langner BM; Jackson N; Alex C; McMahon LL
    J Neurosci; 2021 Jun; 41(26):5747-5761. PubMed ID: 33952633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant LATE-NC in Alzheimer's disease is not associated with increased tau or amyloid-β pathological burden.
    McAleese KE; Walker L; Erskine D; Johnson M; Koss D; Thomas AJ; Attems J
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):722-734. PubMed ID: 32896913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method.
    Yang Y; Schmitt HP
    Acta Neuropathol; 2001 Mar; 101(3):256-70. PubMed ID: 11307626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spatiotemporal characterization of cellular tau pathology in the human locus coeruleus-pericoerulear complex by three-dimensional imaging.
    Gilvesy A; Husen E; Magloczky Z; Mihaly O; Hortobágyi T; Kanatani S; Heinsen H; Renier N; Hökfelt T; Mulder J; Uhlen M; Kovacs GG; Adori C
    Acta Neuropathol; 2022 Oct; 144(4):651-676. PubMed ID: 36040521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau.
    McCollum LE; Das SR; Xie L; de Flores R; Wang J; Xie SX; Wisse LEM; Yushkevich PA; Wolk DA;
    Neuroimage Clin; 2021; 31():102717. PubMed ID: 34119903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Widespread Reduced Density of Noradrenergic Locus Coeruleus Axons in the App Knock-In Mouse Model of Amyloid-β Amyloidosis.
    Sakakibara Y; Hirota Y; Ibaraki K; Takei K; Chikamatsu S; Tsubokawa Y; Saito T; Saido TC; Sekiya M; Iijima KM
    J Alzheimers Dis; 2021; 82(4):1513-1530. PubMed ID: 34180416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of in vivo brain glutathione conformers in cingulate cortex among age-matched control, MCI, and AD patients using MEGA-PRESS.
    Shukla D; Mandal PK; Tripathi M; Vishwakarma G; Mishra R; Sandal K
    Hum Brain Mapp; 2020 Jan; 41(1):194-217. PubMed ID: 31584232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease.
    McMillan PJ; White SS; Franklin A; Greenup JL; Leverenz JB; Raskind MA; Szot P
    Brain Res; 2011 Feb; 1373():240-52. PubMed ID: 21147074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of changes in the locus coeruleus in patients with mild cognitive impairment and Alzheimer's disease: high-resolution fast spin-echo T1-weighted imaging.
    Takahashi J; Shibata T; Sasaki M; Kudo M; Yanezawa H; Obara S; Kudo K; Ito K; Yamashita F; Terayama Y
    Geriatr Gerontol Int; 2015 Mar; 15(3):334-40. PubMed ID: 24661561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-dependent dysregulation of locus coeruleus firing in a transgenic rat model of Alzheimer's disease.
    Kelberman MA; Rorabaugh JM; Anderson CR; Marriott A; DePuy SD; Rasmussen K; McCann KE; Weiss JM; Weinshenker D
    Neurobiol Aging; 2023 May; 125():98-108. PubMed ID: 36889122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease.
    Tremblay C; François A; Delay C; Freland L; Vandal M; Bennett DA; Calon F
    J Neuropathol Exp Neurol; 2017 Feb; 76(2):70-88. PubMed ID: 28158844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complex noradrenergic dysfunction in Alzheimer's disease: Low norepinephrine input is not always to blame.
    Gannon M; Wang Q
    Brain Res; 2019 Jan; 1702():12-16. PubMed ID: 29307592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer's disease.
    Matchett BJ; Grinberg LT; Theofilas P; Murray ME
    Acta Neuropathol; 2021 May; 141(5):631-650. PubMed ID: 33427939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
    Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
    J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.
    Mistridis P; Krumm S; Monsch AU; Berres M; Taylor KI
    J Alzheimers Dis; 2015; 48(4):1095-107. PubMed ID: 26402083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress-mediated activation of extracellular signal-regulated kinase contributes to mild cognitive impairment-related mitochondrial dysfunction.
    Gan X; Wu L; Huang S; Zhong C; Shi H; Li G; Yu H; Howard Swerdlow R; Xi Chen J; Yan SS
    Free Radic Biol Med; 2014 Oct; 75():230-40. PubMed ID: 25064321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.